Ribonucleic Acid News and Research

RSS
scRNA-seq of SARS-CoV-2 infected lung organoids finds NFKB Inhibitor Alpha increased in infected cells

scRNA-seq of SARS-CoV-2 infected lung organoids finds NFKB Inhibitor Alpha increased in infected cells

4 Aug 2022
What is the viral rebound in untreated COVID-19 infections?

What is the viral rebound in untreated COVID-19 infections?

4 Aug 2022
Disease progression in the rhesus macaque model upon inoculation with the Delta, Omicron BA.1, and Omicron BA.2 variants

Disease progression in the rhesus macaque model upon inoculation with the Delta, Omicron BA.1, and Omicron BA.2 variants

4 Aug 2022
Large-scale serological survey of SARS-CoV-2 in multiple rodent species across Europe

Large-scale serological survey of SARS-CoV-2 in multiple rodent species across Europe

4 Aug 2022
A combined influenza and COVID-19 mRNA vaccine

A combined influenza and COVID-19 mRNA vaccine

3 Aug 2022
Hybrid immunity retained six months after SARS-CoV-2 exposure

Hybrid immunity retained six months after SARS-CoV-2 exposure

3 Aug 2022
Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

3 Aug 2022
Low neutralization of Omicron BA.5 after four doses of mRNA COVID-19 vaccine

Low neutralization of Omicron BA.5 after four doses of mRNA COVID-19 vaccine

3 Aug 2022
How do the rates of SARS-CoV-2 shedding into exhaled breath aerosol differ between individuals infected by different variants?

How do the rates of SARS-CoV-2 shedding into exhaled breath aerosol differ between individuals infected by different variants?

3 Aug 2022
The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

3 Aug 2022
Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

2 Aug 2022
Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

2 Aug 2022
Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

2 Aug 2022
Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

2 Aug 2022
How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

2 Aug 2022
What are the hidden sources of SARS-CoV-2 evolution?

What are the hidden sources of SARS-CoV-2 evolution?

2 Aug 2022
CDC study describes safety profile of second mRNA COVID booster

CDC study describes safety profile of second mRNA COVID booster

1 Aug 2022
The first viral metagenomic analysis of the soprano pipistrelle bat of Sweden

The first viral metagenomic analysis of the soprano pipistrelle bat of Sweden

1 Aug 2022
The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

1 Aug 2022
SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

29 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback